Mechanism of microRNA-106a promoting invasion of breast cancer MDA-MB-231 cells
10.3969/j.issn.1000-4718.2018.06.012
- VernacularTitle:MicroRNA-106a促进乳腺癌MDA-MB-231细胞侵袭的机制研究
- Author:
Zhi-Ping LIU
1
;
Meng-Lin YUE
Author Information
1. 平顶山学院医学院
- Keywords:
MicroRNA-106a;
Breast cancer;
Neoplasm invasion;
Tissue inhibitor of metalloproteinase 2
- From:
Chinese Journal of Pathophysiology
2018;34(6):1031-1036
- CountryChina
- Language:Chinese
-
Abstract:
AIM:To investigate the possible mechanism of microRNA-106a promoting the invasion of human breast cancer MDA-MB-231 cells. METHODS:The efficiencies of transfection with microRNA-106a inhibitor and mi-croRNA-106a mimic by liposome were detected by qPCR. The mRNA and protein expression levels of tissue inhibitor of metalloproteinase 2 (TIMP-2), matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MMP9) in the MDA-MB-231 cells transfected with microRNA-106a mimic were detected by qPCR and Western blot. The effect of microRNA-106a on the invasion ability of MDA-MB-231 cells was measured by Transwell assay. The luciferase reporter assay was used to detect the regulatory effect of microRNA-106a on the TIMP-2 pathway. RESULTS:In the MDA-MB-231 cells, the ex-pression level of microRNA-106a decreased at 48 h after transfection with microRNA-106a inhibitor (P<0.05), and the expression level of microRNA-106a increased at 48 h after transfection with microRNA-106a mimic (P<0.05). The mi-croRNA-106a inhibitor decreased the invasion ability of MDA-MB-231 cells in vitro (P<0.05). The microRNA-106a mim-ic down-regulated the expression of TIMP-2 and up-regulated the expression of MMP2 and MMP9 (P<0.05) in the MDA-MB-231 cells. The microRNA-106a inhibitor enhanced the luciferase activity of the reporter plasmids containing the 3'-un-translated region of TIMP-2 gene (P<0.05), while the microRNA-106a mimic decreased the luciferase activity of the re-porter plasmid (P<0.05). CONCLUSION:High expression of microRNA-106a promotes the invasion ability of breast cancer MDA-MB-231 cells in vitro, which may be related to the inhibition of TIMP-2 pathway. MicroRNA-106a plays an important role in the invasion of breast cancer MDA-MB-231 cells.
